These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 17043158

  • 1. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV, Agalakova NI, Morrell CH, Lakatta EG, Bagrov AY.
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [Abstract] [Full Text] [Related]

  • 2. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY, Fedorova OV.
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV, Bagrov AY.
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [Abstract] [Full Text] [Related]

  • 4. Age-associated increase in salt sensitivity is accompanied by a shift in the atrial natriuretic peptide modulation of the effect of marinobufagenin on renal and vascular sodium pump.
    Fedorova OV, Kashkin VA, Zakharova IO, Lakatta EG, Bagrov AY.
    J Hypertens; 2012 Sep; 30(9):1817-26. PubMed ID: 22796708
    [Abstract] [Full Text] [Related]

  • 5. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
    Fedorova OV, Zhuravin IA, Agalakova NI, Yamova LA, Talan MI, Lakatta EG, Bagrov AY.
    J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
    [Abstract] [Full Text] [Related]

  • 6. Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanism.
    Bagrov AY, Dmitrieva RI, Dorofeeva NA, Fedorova OV, Lopatin DA, Lakatta EG, Droy-Lefaix MT.
    J Hypertens; 2000 Feb; 18(2):209-15. PubMed ID: 10694190
    [Abstract] [Full Text] [Related]

  • 7. Phorbol diacetate potentiates na(+)-k(+) ATPase inhibition by a putative endogenous ligand, marinobufagenin.
    Fedorova OV, Dorofeeva NA, Lopatin DA, Lakatta EG, Bagrov AY.
    Hypertension; 2002 Feb; 39(2):298-302. PubMed ID: 11847201
    [Abstract] [Full Text] [Related]

  • 8. Atrial natriuretic peptide modulates sodium and potassium-activated adenosine triphosphatase through a mechanism involving cyclic GMP and cyclic GMP-dependent protein kinase.
    Scavone C, Scanlon C, McKee M, Nathanson JA.
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1036-43. PubMed ID: 7891313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activity.
    Bagrov AY, Dmitrieva RI, Fedorova OV, Kazakov GP, Roukoyatkina NI, Shpen VM.
    Am J Hypertens; 1996 Oct; 9(10 Pt 1):982-90. PubMed ID: 8896650
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The opposite effects of cyclic AMP-protein kinase a signal transduction pathway on renal cortical and medullary Na+,K+-ATPase activity.
    Bełtowski J, Marciniak A, Wójcicka G, Górny D.
    J Physiol Pharmacol; 2002 Jun; 53(2):211-31. PubMed ID: 12120897
    [Abstract] [Full Text] [Related]

  • 19. Plasma marinobufagenin-like and ouabain-like immunoreactivity in adrenocorticotropin-treated rats.
    Fedorova OV, Anderson DE, Bagrov AY.
    Am J Hypertens; 1998 Jul; 11(7):796-802. PubMed ID: 9683040
    [Abstract] [Full Text] [Related]

  • 20. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
    Arnaud-Batista FJ, Costa GT, Oliveira IM, Costa PP, Santos CF, Fonteles MC, Uchôa DE, Silveira ER, Cardi BA, Carvalho KM, Amaral LS, Pôças ES, Quintas LE, Noël F, Nascimento NR.
    Am J Physiol Renal Physiol; 2012 Apr 15; 302(8):F959-66. PubMed ID: 22237798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.